Cargando…
Barriers and Facilitators to the Elimination of Asbestos Related Diseases—Stakeholders’ Perspectives
Despite sound scientific knowledge and evidence that any exposure to asbestos fibers in all of its forms, are carcinogenic to humans, its presence, use and trade is still substantial, including in the World Health Organization (WHO) European Region. Banning the production and use of all forms of asb...
Autores principales: | Vincenten, Joanne, George, Frank, Martuzzi, Marco, Schröder-Bäck, Peter, Paunovic, Elizabet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664770/ https://www.ncbi.nlm.nih.gov/pubmed/29065497 http://dx.doi.org/10.3390/ijerph14101269 |
Ejemplares similares
-
Priorities for improving chemicals management in the WHO European Region—stakeholders’ views
por: Vincenten, Joanne A, et al.
Publicado: (2020) -
Development of the “National Asbestos Profile” to Eliminate Asbestos-Related Diseases in 195 Countries
por: Arachi, Diana, et al.
Publicado: (2021) -
Preventive Measures to Eliminate Asbestos-Related Diseases in Singapore
por: Lim, John Wah, et al.
Publicado: (2011) -
Invited Perspective: Eliminating Toxics to Prevent Disease: Asbestos Leads the Way
por: Kriebel, David, et al.
Publicado: (2022) -
Stakeholder Perspectives on Barriers and Facilitators for the Adoption of Virtual Clinical Trials: Qualitative Study
por: Coert, Romée Melanie Helena, et al.
Publicado: (2021)